Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-15-004203
Filing Date
2015-05-14
Accepted
2015-05-14 17:05:34
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vericel3311510q.htm 10-Q 630722
2 EXHIBIT 31.1 - CEO CERTIFICATION ex311.htm EX-31.1 11817
3 EXHIBIT 31.2 - CFO CERTIFICATION ex312.htm EX-31.2 11863
4 EXHIBIT 32.1 - CEO SOX CERTIFICATION ex321.htm EX-32.1 7012
5 EXHIBIT 32.2 - CFO SOX CERTIFICATION ex322.htm EX-32.2 7024
  Complete submission text file 0001628280-15-004203.txt   5306854

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT astm-20150331.xml EX-101.INS 729479
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT astm-20150331.xsd EX-101.SCH 34572
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT astm-20150331_cal.xml EX-101.CAL 73921
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT astm-20150331_def.xml EX-101.DEF 144422
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT astm-20150331_lab.xml EX-101.LAB 522279
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT astm-20150331_pre.xml EX-101.PRE 266653
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35280 | Film No.: 15863870
SIC: 2836 Biological Products, (No Diagnostic Substances)